Investigating inflammatory factors in diabetic eye disease
Ocular Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy
This study is looking at how certain substances in the eye might help us understand and treat diabetic retinopathy better, so we can catch it earlier and help prevent vision loss for people with diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10927270 on NIH RePORTER |
What this research studies
This research focuses on diabetic retinopathy, a leading cause of blindness, by exploring the role of inflammatory mediators in the eye. It aims to identify new biomarkers that can predict disease progression and response to treatment, moving beyond current methods that often fail to detect early stages of the disease. The study will analyze the levels of specific inflammatory cytokines in the eyes of patients to understand their correlation with the severity of diabetic retinopathy. By doing so, it seeks to develop new therapeutic strategies that could improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with diabetes and may be at risk for diabetic retinopathy.
Not a fit: Patients who do not have diabetes or those with advanced stages of diabetic retinopathy that are unresponsive to treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and more effective treatments for diabetic retinopathy, potentially reducing the risk of blindness.
How similar studies have performed: Previous research has shown promise in using inflammatory markers for predicting disease progression in other conditions, suggesting potential success for this novel approach in diabetic retinopathy.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Kim, Stephen Jae — Vanderbilt University Medical Center
- Study coordinator: Kim, Stephen Jae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.